Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 1, 2000, Pages 19-26

  Convit, A ^a   De Asis, J ^b   De Leon, M J ^a   Tarshish, C Y ^a   De Santi, S ^a   Rusinek, H ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Alzheimer's Disease; Fusiform gyrus; Magnetic resonance imaging; Medial occipitotemporal gyrus; Middle and inferior temporal gyri; Minimal cognitive impairment; Prediction of AD

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLASSIFICATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PREDICTION; PRIORITY JOURNAL; TEMPORAL LOBE;

AGE FACTORS; AGED; ALZHEIMER DISEASE; ATROPHY; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PARAHIPPOCAMPAL GYRUS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TEMPORAL LOBE;

EID: 0007234813     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00107-4     Document Type: Article

References (42)

1. Ball M.J. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study. Neuropathologica. 42:1978;73-80.
2. Berg L. Clinical dementia rating (CDR). Psychopharmacol Bull. 24:1988;637-639.
3. Bobinski M., de Leon M.J., Wegiel J., De Santi S., Convit A., Wisniewski H.M. The histological validation of MRI hippocampal volume measurements in Alzheimer disease. Neuroscience. 95:2000;721-725.
4. Bouras C., Hof P.R., Morrison J.H. Neurofibrillary tangle densities in the hippocampal formation in a nondemented population define subgroups of patients with differential early pathologic changes. Neurosci Lett. 153:1993;131-135.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica. 82:1991;239-259.
6. Braak H., Braak E., Bohl J. Staging of Alzheimer-related cortical destruction. European Neurol. 33:1993;403-408.
7. Clark R.F., Goate A.M. Molecular genetics of Alzheimer's disease. Arch Neurol. 50:1993;1164-1172.
8. Cockrell J.R., Folstein M.F. Mini-mental state examination (MMSE). Psychopharmacol Bull. 24:1988;689-692.
9. Coffey C.E., Wilkinson W.E., Parashos I.A., Soady S.A.R., Sullivan R.J., Patterson L.J., Figiel G.S., Webb M.C., Spritzer C.E., Djang W.T. Quantitative cerebral anatomy of the aging human brain a cross-sectional study using magnetic resonance imaging . Neurology. 42:1992;527-536.
10. Coleman P.D., Flood D.G. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging. 8:1987;521-545.
11. Convit A., de Leon M.J., Hoptman M.J., Tarshish C., De Santi S., Rusinek H. Age-related changes in brain. I. Magnetic resonance imaging measure of temporal lobe volumes in normal subjects. Psychiatr Q. 66:1995;343-355.
12. Convit A., de Leon M.J., Tarshish C., De Santi S., Kluger A., Rusinek H., George A. Hippocampal volume losses in minimally impaired elderly. Lancet. 345:1995;266.
13. Convit A., de Leon M.J., Tarshish C., De Santi S., Tsui W., Rusinek H., George A.E. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging. 18:1997;131-138.
14. de Leon M.J., Ferris S.H., George A.E., Christman D.R., Fowler J.S., Gentes C., Reisberg B., Gee B., Emmerich M., Yonekura Y., Brodie J., Kricheff I.I., Wolf A.P. Positron emission tomography studies of aging and Alzheimer's disease. Am J Neuroradiol. 4:1983;568-571.
15. de Leon M.J., George A.E., Golomb J., Tarshish C., Convit A., Kluger A., De Santi S., McRae T., Ferris S.H., Reisberg B., Ince C., Rusinek H., Bobinski M., Quinn B., Miller D.C., Wisniewski H.M. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging. 18:1997;1-11.
16. de Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C. Early marker for Alzheimer's disease the atrophic hippocampus . Lancet. 2:1989;672-673.
17. de Leon M.J., Golomb J., George A.E., Convit A., Tarshish C.Y., McRae T., De Santi S., Smith G., Ferris S.H., Noz M., Rusinek H. The radiologic prediction of Alzheimer's disease the atrophic hippocampal formation . Am J Neuroradiol. 14:1993;897-906.
18. Flicker C., Ferris S.H., Reisberg B. Mild cognitive impairment in the elderly predictors of dementia . Neurology. 41:1991;1006-1009.
19. Foster N.L., Chase T.N., Mansi L., Brooks R., Fedio P., Patronas N.J., Di Chiro G. Cortical abnormalities in Alzheimer's disease. Ann Neurol. 16:1984;649-654.
20. Gilbert J.G., Levee R.F. Patterns of declining memory. J Gerontol. 26:1971;70-75.
21. Gilbert J.G., Levee R.F., Catalano F.L. A preliminary report on a new memory scale. Percept Motor Skills. 27:1968;277-278.
22. Golomb J., de Leon M.J., Kluger A., George A.E., Tarshish C., Ferris S.H. Hippocampal atrophy in normal aging an association with recent memory impairment . Arch Neurol. 50:1993;967-973.
23. Golomb J., Kluger A., de Leon M.J., Ferris S.H., Convit A., Mittelman M.S., Cohen J., Rusinek H., De Santi S., George A. Hippocampal formation size in normal human aging a correlate of delayed secondary memory performance . Learn Mem. 1:1994;45-54.
24. Gur R.C., Mozley P.D., Resnick S.M., Gottlieb G.L., Kohn M., Zimmerman R., Herman G., Atlas S., Grossman R., Berretta D., Erwin R., Gur R.E. Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proceed Nat Acad Sci. 88:1991;2845-2849.
25. Hubbard B.M., Anderson J.M. A quantitative study of cerebral atrophy in old age and senile dementia. J Neurologic Sci. 50:1981;135-145.
26. Jack C.R., Petersen R.C., O'Brien P.C., Tangalos E.G. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurol. 42:1992;183-188.
27. Jack C.R.J., Petersen R.C., Xu Y., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 51:1998;993-999.
28. Jobst K.A., Barnetson L.P.D., Shepstone B.J. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT and Apo E4 in medial temporal lobe dementia . Int Psychogeriat. 10:1998;271-302.
29. Kapur N., Friston K.J., Young A., Frith C.D., Frackowiak R.S.J. Activation of human hippocampal formation during memory for faces a PET study . Cortex. 31:1995;99-108.
30. Kaye J.A., Swihart T., Howieson D., Dame A., Moore M.M., Karnos T., Camicioli R., Ball M., Oken B., Sexton G. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Am Acad Neurol. 48:1997;1287-1304.
31. Kemper T. Neuroanatomical and neuropathological changes in normal aging and in dementia. Albert M.L., Clinical neurology of aging. 1984;3-67 Oxford University Press, New York.
32. Kennedy A.M., Frackowiak R.S.J., Newman S.K., Bloomfield P.M., Seaward J., Roques P., Lewington G., Cunningham V.L., Rossor M.N. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's Disease. Neurosci Lett. 186:1995;17-20.
33. Larrabee G.J., Crook T.H. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriat. 6:1994;95-104.
34. Mann D.M.A. The topographic distribution of brain atrophy in Alzheimer's disease. Acta Neuropathologica. 83:1991;81-86.
35. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's disease . Neurology. 34:1984;939-944.
36. Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 12:1991;295-312.
37. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiat. 139:1982;1136-1139.
38. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale (GDS). Psychopharmacol Bull. 24:1988;661-663.
39. Saunders A.M., Hulette C., Welsh-Bohmer K.A., Schmechel D.E., Crain B., Burke J.R., Alberts M.J., Strittmatter W.J., Breitner J.C.S., Rosenberg C., Scott S.V., Gaskell P.C. Jr, Pericak-Vance M.A., Roses A.D. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet. 348:1996;90-93.
40. Schoenberg B.S. Epidemiology of Alzheimer's disease and other dementing disorders. J Chronic Disease. 39:1986;1095-1104.
41. Tsui WT. Multimodal Image Data Analysis System (MIDAS), Version 1.0. 1995, Unpublished Manual.
42. Wechsler D. Wechsler Adult Intelligence Scale. New York: Psychological Corporation; 1955.